ARTICLE TYPE : CASE REPORT
Published on : 22 Dec 2025, Volume - 1
Journal Title : WebLog Journal of Pharmacology and Therapeutics | WebLog J Pharmacol Ther
Source URL:
https://weblogoa.com/articles/wjpt.2025.l2201
Permanent Identifier (DOI) :
https://doi.org/10.5281/zenodo.18058157
Sertraline-Induced Lipase-Sparing Acute Interstitial Edematous Pancreatitis: A Case Report
2Department of Pediatric Surgery, PGICHR and KTCGUH, Rajkot 360001, Gujarat, India
3Department of Pediatric Surgery, Nottingham University Hospitals, Nottingham, UK
4Lincoln University College, Lincoln University, Kuala Lumpur, Malaysia
5J. Watumull Global Hospital & Research Centre, Delwara Road, Mount Abu, Rajasthan 307501, India Affiliated to Medical Faculty of God Fatherly Spiritual University, Mount Abu, Rajasthan, India
Abstract
Sertraline, a selective serotonin reuptake inhibitor (SSRI), has been associated with rare cases of acute pancreatitis. We report a case of sertraline-induced, lipase-sparing acute interstitial edematous pancreatitis in a young professional, initially misdiagnosed as acute cholecystitis. On rechallenge, the patient developed recurrent symptoms with elevated inflammatory markers but normal ultrasound findings. Contrast-enhanced computed tomography confirmed acute interstitial edematous pancreatitis with associated venous thrombosis. Withdrawal of sertraline and substitution with an alternative antidepressant led to complete resolution. This case highlights the diagnostic challenge of lipase-sparing pancreatitis and underscores the importance of considering drug-induced etiologies.
Keywords: Acute Pancreatitis; Antidepressant; Cholecystitis; Drug-Induced; Lipase; Sertraline; Ssris; Adverse Effects
Citation
Zaparackaite I, Singh H, Singh SJ, Swamy KB, Midha PK, Patel RV. Sertraline-Induced Lipase Sparing Acute Interstitial Edematous Pancreatitis: A Case Report. WebLog J Pharmacol Ther. wjpt.2025.l2201. https://doi.org/10.5281/zenodo.18058157